Resources

Selected
  • Systematic reviews (SYSVAC)
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date
2853 results found
2025 ∙ Zarekar, M. Al-Shehabi, H. Dorner, R. Weishaar, H. Lennemann, T. El Bcheraoui, C. Bernasconi, A.
The impact of information and communication technology on immunisation and immunisation programmes in low-income and middle-income countries: a systematic review and meta-analysis
Children Low and Middle Income Countries Coverage Logistics
Rating:
Not applicable
2025 ∙ Wu, W. Liu, J. Guo, S. Zhao, H. Yang, X.
The protective efficacy of inactivated vaccine against hemorrhagic fever with renal syndrome A meta-analysis
All age groups Efficacy/effectiveness
Rating:
Critically low
2025 ∙ Robitaille, J. Esser, K. King, C. Leask, J. Wiley, K. Vigod, S. Rodin, G. Bolotin, S. Shapiro, G. K.
The Relationship Between Postpartum Depression and Timely Child Vaccination: A Systematic Review
Newborn Children Coverage
Rating:
Not applicable
2025 ∙ Shuai, T. Dong, M. Wu, P. Zhang, L. Feng, Z. Li, W. Liu, J.
The safety and efficacy of non-typeable Haemophilus influenzae and Moraxella catarrhalis vaccine in chronic obstructive pulmonary disease: a systematic review and meta-analysis of randomized controlled trials
All age groups Haemophilus influenzae type B Moraxella catarrhalis Efficacy/effectiveness Safety
Rating:
Moderate
2025 ∙ Valdecantos, R. L. Sorrentino, M. Mercogliano, M. Giordano, V. Trama, U. Triassi, M. Palladino, R.
The structural and organizational aspects of human papillomavirus vaccine affecting immunization coverage in Europe: a systematic review
Europe Adolescents Adults Older adults Human papillomavirus (HPV) Coverage
Rating:
Not applicable
2025 ∙ Jacobsen, I. M. Carlander, A. L. F. Aakilde, M. von Buchwald, C.
Trends in the incidence and prevalence of juvenile-onset recurrent respiratory papillomatosis following implementation of national HPV vaccination initiatives: a systematic review
Adolescents Adults Human papillomavirus (HPV) Efficacy/effectiveness Coverage
Rating:
Critically low
2025 ∙ Gloeck, N. R. Leong, T. D. Mthethwa, M. Iwu-Jaja, C. J. Katoto, Pdmc Wiysonge, C. S. Kredo, T.
Typhoid conjugate vaccines for preventing typhoid fever (enteric fever)
Children Adolescents Adults Older adults Typhoid Efficacy/effectiveness Safety Administration
Rating:
High
2025 ∙ Bardach, A. Brizuela, M. Berrueta, M. Ciapponi, A. Sambade, J. M. Ballivian, J. Ortega, V. Castellana, N. Comande, D. Parker, E. P. K. Kampmann, B. Stegelmann, K. Xiong, X. Stergachis, A. Munoz, F. M. Buekens, P. Mazzoni, A.
Umbrella review of the safety of Chikungunya vaccine platforms used in other vaccines
Pregnant women Newborn Children Adolescents Chikungunya Safety
Rating:
Not applicable
2025 ∙ Satyam, S. M. El-Tanani, M. Bairy, L. K. Rehman, A. Srivastava, A. Kenneth, J. M. Prem, S. M.
Unraveling Cardiovascular Risks and Benefits of COVID-19 Vaccines: A Systematic Review
All age groups COVID-19 Efficacy/effectiveness Safety
Rating:
Critically low
2025 ∙ Jafari, Z. Kolb, B. E. Aiken, S. Wilson, S.
Updates on Auditory Outcomes of COVID-19 and Vaccine Side Effects: An Umbrella Review
All age groups Pregnant women COVID-19 Safety
Rating:
Not applicable
Loading...